Xeljanz Side Effects 2019
July 28, 2021
In 2019, The FDA has linked Xeljanz to the following serious side effects: cancer, cardiovascular events, and venous thromboembolism. Xeljanz Side Effects: Major Adverse Cardiovascular Events Xeljanz has been linked to a greater rate of major adverse cardiovascular events, including: Cardiac arrest Cardiovascular death Congestive heart failure Coronary revascularization Myocardial